[RGLS] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
12-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 9.77%
YoY- 42.86%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 5,000 0 6 18 18 18 6,778 -18.31%
PBT -1,523 -6,947 -5,945 -4,893 -5,423 -5,015 -3,260 -39.70%
Tax 1 10 -8 -131 87 1 56 -93.11%
NP -1,524 -6,947 -5,937 -4,893 -5,423 -5,016 -3,260 -39.68%
Tax Rate - - - - - - - -
Total Cost 6,524 6,947 5,943 4,911 5,441 5,034 10,038 -24.90%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -30.48 0.00 -98,950.00 -27,183.33 -30,127.78 -27,866.67 -48.10 -26.16%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.40 -2.33 -2.47 -2.34 -2.60 -3.00 -3.14 -74.58%
EPS Diluted -0.40 -2.33 -2.47 -2.34 -2.60 -3.00 -3.14 -74.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.